On the HCPLive Internal Medicine condition center page, resources on the topics of medical news and expert insight into internal medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on internal medicine research, treatment, and drug development.
February 4th 2025
Most deprescribing interventions consist of a clinician being alerted to a potential problem with the patient’s medication but does not provide guidance to the clinician about how to communicate with the patient.
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Internal Medicine Meeting
April 3, 2025
Register Now!
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies
View More
Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis
View More
Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
View More
More Than Half of IBD Patients in China Have Poor Response to Anti-TNF Treatment
Some indicators of suboptimal response included discontinuation of anti-TNF therapy for patients with ulcerative colitis and IBD-related hospitalization for patients with Crohn’s disease.
SGLT2 Inhibitors, GLP-1 RAs Could Lower NAFLD Risk in Type 2 Diabetes
February 4th 2022Comparing SGLT2 inhibitor and GLP-1 RA use versus DPP-4 inhibitors in patients with type 2 diabetes, investigators found use of newer glycemic agents could provide protection against NAFLD in addition to their cardiorenal protective benefits.
Increased Oxytocin Levels Could Be Driving Hypersexual Disorder in Men
February 3rd 2022New research suggests men with hypersexual disorder had increased plasma oxytocin levels and indicate cognitive-behavioral therapy was associated with a decrease in these levels as well as symptoms of hypersexual disorder.